Literature DB >> 21356285

Enhanced cellular association of paclitaxel delivered in chitosan-PLGA particles.

Sudhir S Chakravarthi1, Dennis H Robinson.   

Abstract

We have previously demonstrated that the cellular association, cytotoxicity, and in vivo anti-tumor efficacy of paclitaxel are significantly greater when delivered in PLGA microparticles compared to nanoparticles. The purpose of this research is to test the hypothesis that mucoadhesive chitosan promotes adhesion of PLGA particles to mucus on the tumor epithelium, resulting in enhanced cellular association and cytotoxicity of paclitaxel. PLGA particles containing paclitaxel or Bodipy(®) were prepared and chitosan was either adsorbed or chemically conjugated to the particle surface. The cellular association and cytotoxicity of paclitaxel in 4T1 cells was determined. A 4-10 fold increase in cellular association of paclitaxel was observed when chitosan was adsorbed or conjugated to the PLGA particles. Chitosan-conjugated PLGA microparticles were most cytotoxic with an IC(50) value of 0.77 μM. Confocal microscopy demonstrated that chitosan-PLGA microparticles adhered to the surface of 4T1 cells. Pretreatment of either 4T1 cells or chitosan-PLGA particles with mucin resulted in significant increase in cellular association of paclitaxel. A linear correlation was established between theoretical amount of chitosan used and experimentally determined amount of chitosan adsorbed or conjugated to PLGA nanoparticles. In conclusion, cellular association and cytotoxicity of paclitaxel was significantly enhanced when delivered in chitosan-PLGA particles.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21356285     DOI: 10.1016/j.ijpharm.2011.02.034

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  15 in total

Review 1.  Strategies to target tumors using nanodelivery systems based on biodegradable polymers, aspects of intellectual property, and market.

Authors:  Michele F Oliveira; Pedro P G Guimarães; Alinne D M Gomes; Diego Suárez; Rubén D Sinisterra
Journal:  J Chem Biol       Date:  2012-11-30

2.  An In Vitro Thrombolysis Study Using a Mixture of Fast-Acting and Slower Release Microspheres.

Authors:  Hoai X Nguyen; Edgar A O'Rear
Journal:  Pharm Res       Date:  2016-03-10       Impact factor: 4.200

3.  Quantification of particle-conjugated or particle-encapsulated peptides on interfering reagent backgrounds.

Authors:  Woon Teck Yap; W Kelsey Song; Niharika Chauhan; P Nina Scalise; Radhika Agarwal; Stephen D Miller; Lonnie D Shea
Journal:  Biotechniques       Date:  2014-07-01       Impact factor: 1.993

4.  Paclitaxel Nano-Delivery Systems: A Comprehensive Review.

Authors:  Ping Ma; Russell J Mumper
Journal:  J Nanomed Nanotechnol       Date:  2013-02-18

5.  Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4.

Authors:  Mengshu Wang; Yong Zhang; Jiao Feng; Tiejun Gu; Qingguang Dong; Xu Yang; Yanan Sun; Yongge Wu; Yan Chen; Wei Kong
Journal:  Int J Nanomedicine       Date:  2013-03-15

6.  Enhanced in vitro antiproliferative effects of EpCAM antibody-functionalized paclitaxel-loaded PLGA nanoparticles in retinoblastoma cells.

Authors:  Moutushy Mitra; Ranjita Misra; Anju Harilal; Sanjeeb K Sahoo; Subramanian Krishnakumar
Journal:  Mol Vis       Date:  2011-10-19       Impact factor: 2.367

7.  Local delivery of cannabinoid-loaded microparticles inhibits tumor growth in a murine xenograft model of glioblastoma multiforme.

Authors:  Dolores Hernán Pérez de la Ossa; Mar Lorente; Maria Esther Gil-Alegre; Sofía Torres; Elena García-Taboada; María Del Rosario Aberturas; Jesús Molpeceres; Guillermo Velasco; Ana Isabel Torres-Suárez
Journal:  PLoS One       Date:  2013-01-22       Impact factor: 3.240

8.  Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes.

Authors:  Changkyu Lee; Ji Su Choi; Insoo Kim; Kyung Taek Oh; Eun Seong Lee; Eun-Seok Park; Kang Choon Lee; Yu Seok Youn
Journal:  Int J Nanomedicine       Date:  2013-08-09

9.  Fate of paclitaxel lipid nanocapsules in intestinal mucus in view of their oral delivery.

Authors:  Anne-Claire Groo; Patrick Saulnier; Jean-Christophe Gimel; Julien Gravier; Caroline Ailhas; Jean-Pierre Benoit; Frederic Lagarce
Journal:  Int J Nanomedicine       Date:  2013-11-07

10.  Bone regeneration by nanohydroxyapatite/chitosan/poly(lactide-co-glycolide) scaffolds seeded with human umbilical cord mesenchymal stem cells in the calvarial defects of the nude mice.

Authors:  Fei Wang; Xiao-Xia Su; Yu-Cheng Guo; Ang Li; Yin-Cheng Zhang; Hong Zhou; Hu Qiao; Li-Min Guan; Min Zou; Xin-Qin Si
Journal:  Biomed Res Int       Date:  2015-10-13       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.